Latest Insights

Insilico Medicine Reports AI-Designed PROTAC That Degrades and Inhibits PKMYT1

This month, Insilico Medicine has published a paper in Nature Communications describing an AI-generated PROTAC that targets PKMYT1, a kinase linked to synthetic lethality in cancers with CCNE1 amplification or …

Continue ›››

Why European Life Science’s Momentum May Finally Become Unstoppable

Living in Europe and watching the scene firsthand, it seems biotech here doesn’t revolve around a single gravitational center. There’s no Kendall Square-kind of place here, no San Francisco–style mega-cluster …

Continue ›››

AI and Cryo-EM: A Powerful Alliance for Unraveling Biological Mysteries

As we advance further into the territories of biotechnology, the convergence of artificial intelligence (AI) and cryo-electron microscopy (Cryo-EM) has emerged as a powerful partnership for unlocking complex biological structures. …

Continue ›››

9 Notable Companies Enabling Decentralized Clinical Trials

Decentralized clinical trials (DCTs) are not a recent invention, but their adoption has accelerated as logistical complexity, geographic dispersion, and patient burden have come under scrutiny. The shift began long …

Continue ›››

Generative Diffusion in Molecular Design

A quick field guide to diffusion-based generators in molecular design—how they work, where they complement transformers, and who is deploying them today. Last week, Californian drug discovery startup Terray Therapeutics …

Continue ›››

9 Companies Using Artificial Intelligence to Fight Infectious Diseases

Development of a novel drug is a tedious process that requires immense investments of resources and time—on average, it takes from 8-10 years and capitalized R&D costs are reported between …

Continue ›››

Ginkgo Bioworks Launches Open-Source Pharmacology Framework for AI Drug Discovery

Ginkgo Bioworks has introduced the Virtual Cell Pharmacology Initiative (VCPI) through its Ginkgo Datapoints division, creating what it describes as the first open-source pharmacological framework for virtual cell modeling. The …

Continue ›››

Three Big Ideas in Aging Research That Could Shift the Therapeutic Landscape

Drawing on new discussions from ARDD2025 in Copenhagen, the focus turns to how GLP-1s, IPF, and the gut microbiome are steering aging drug development Over the past decade, aging research …

Continue ›››

Antheia and TAPI Announce Strategic Partnership to Scale Biosynthetic Pharmaceutical Manufacturing

Antheia and TAPI have formed a strategic partnership to accelerate global commercialization of Antheia’s biosynthetic manufacturing platform for key starting materials (KSMs) and active pharmaceutical ingredients (APIs). The collaboration integrates …

Continue ›››